Digital intervention to improve maternal healthcare engagement in Brooklyn
Brooklyn Digital Community Care Intervention to Address Unmet Social Needs and Optimize Engagement in Maternal Health Care
This study is testing a digital support program to see if it helps pregnant Black women in Brooklyn get better postpartum care compared to usual services.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 49 Years |
| Sex | Female |
| Sponsor | State University of New York - Downstate Medical Center Academic / other |
| Locations | 1 site (Brooklyn, New York) |
| Trial ID | NCT05916534 on ClinicalTrials.gov |
What this trial studies
This clinical trial tests a digital behavioral intervention called WeCAB aimed at improving postpartum care engagement among pregnant Black women in Central Brooklyn. Participants will receive support from a dedicated community health worker trained in digital care navigation. The study compares the WeCAB intervention group to a control group receiving usual care to determine if the intervention leads to higher rates of early postpartum care utilization. The trial will enroll participants from 13 weeks gestation through delivery, allowing for follow-up up to three months postpartum.
Who should consider this trial
Good fit: Ideal candidates are pregnant Black women aged 18-49 residing in Central Brooklyn who plan to deliver at University Hospital at Downstate.
Not a fit: Patients planning to move outside of New York City within three months postpartum or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance postpartum care engagement among Black women in Brooklyn, leading to better maternal health outcomes.
How similar studies have performed: While similar digital interventions have shown promise in improving healthcare engagement, this specific approach targeting Black pregnant women in Brooklyn is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible participants for the pilot RCT will be patients * aged 18-49 years (childbearing age) * residing in a Central Brooklyn zip code * self-reporting as Black, * who speak English or Haitian Creole, and * plan to deliver or present for delivery at University Hospital at Downstate (UHD). * In NYC, SMM increases incrementally with later entry into prenatal care (1st trimester: 208/10,000 deliveries; 2nd trimester: 252/10,000; 3rd trimester: 297/10,000; None: 575/10,000). 3 Accordingly, in order to capture the full range of SMM risk profiles for our pilot study, any pregnant patient/client visiting our clinics will be eligible for enrollment from 13 weeks gestation through delivery, thus allowing follow-up to 3 months post-partum within the 2-year study timeline. Exclusion Criteria: * Patients planning to move outside of New York City in the ensuing 3 months post-partum * Patients demonstrating an impairment that limits their ability to provide informed consent.
Where this trial is running
Brooklyn, New York
- University Hospital at Downstate — Brooklyn, New York, United States (Recruiting)
Study contacts
- Principal investigator: Aimee Afable, PHD — SUNY Downstate
- Study coordinator: Aimee Afable, PHD
- Email: aimee.afable@downstate.edu
- Phone: 718-270-6397
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.